Lundberg, Elena
Kriström, Berit
Zouater, Hichem
Deleskog, Anna
Höybye, Charlotte
Funding for this research was provided by:
Sandoz (NA)
Article History
Received: 2 October 2019
Accepted: 12 April 2020
First Online: 29 April 2020
Ethics approval and consent to participate
: The PATRO studies were approved by the Ethics Committee at the University of Lund, Lund, Sweden (PATRO Children: NR 2009/765) and at Stockholm, Sweden (PATRO Adults: NR 2011/1212–31). Written informed consent was obtained from participants (and/or their parents/guardians where the patient was aged < 18 years).
: No personal of identifying patient information is included in the manuscript, therefore consent to publish is not required.
: EL has nothing to declare. BK has received honoraria for lectures and consultation from Merck Darmstadt, Novo Nordisk, Pfizer, Sandoz, and GeneScience Pharmaceuticals Co, and has been a member of Pfizer iGRO board since 2013. HZ is an employee of Sandoz Biopharmaceutical c/o HEXAL AG. AD is an employee of Sandoz A/S, Denmark. CH has received honoraria for lectures and consultation from Novo Nordisk, Pfizer, and Sandoz, and is a member of the Global Steering Committee for the PATRO Adults study.